Primary antibodies including PHF10, p-Tau, Tau, SYN, PSD-93, PSD-95, p-AKTser473, AKT, GSK-3β, p-GSK-3βser9, β-cateninSer33, Ser37, Thr41, active β-catenin, β-catenin, Axin1, Bcl-2, Bax, Ac-p53, p53, Sirt1, and GAPDH, as well as secondary antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.